RET and hereditary pheochromocytoma-paraganglioma: It was reported that analysis of patients with RET 634 mutations with and without pheochromocytoma showed that pheochromocytoma was not associated with a more advanced stage of medullary thyroid cancer at diagnosis or a shorter survival (18).